ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Csl Ltd (QX)

Csl Ltd (QX) (CSLLY)

19,98
-0,47
(-2,30%)
Geschlossen 27 Juni 10:00PM

Csl Ltd (QX) (CSLLY) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
19,98
( -2,30% )
Gebot
19,76
Fragen
20,08
Volumen
375.227
19,81 Tagesbereich 20,03
16,01 52-Wochen-Bereich 89,71
Marktkapitalisierung
Handelsende
20,45
Handelsbeginn
19,87
Letzter Handelszeitpunkt
Finanzvolumen
US$ 7.499.989
VWAP
19,9879
Durchschnittliches Volumen (3 Mio.)
US$ 1.845.057
Ausgegebene Aktien
478.911.979
Dividendenrendite (LTM)
2,92
Kurs-Gewinn-Verhältnis
28,51
Gewinn pro Aktie (EPS)
2,86
Erlöse (LTM)
15,41B
Nettogewinn (LTM)
1,4B

Über Csl Ltd (QX)

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, ... CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Melbourne, Australia
Gegründet
2026
Csl Ltd (QX) is listed in the Healthcare sector of the OTC Markets with ticker CSLLY. The last closing price for Csl (QX) was US$20,45. Over the last year, Csl (QX) shares have traded in a share price range of US$ 16,01 to US$ 89,71.

Csl (QX) currently has 478.911.979 shares in issue. The market capitalisation of Csl (QX) is US$9,57 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 28.51.

CSLLY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.120.60422960725119.8620.5491967334319.86547973DR
43.22819.269340974216.75220.54916.0154098018.3027776DR
12-3.57-15.159235668823.5525.8416.0151369420.13061414DR
26-37.86-65.456431535357.8467.063216.0140106426.45755267DR
52-60.97-75.318097591180.9589.7116.0126466836.41091842DR
156-73.37-78.596679164493.3510916.0113854254.45560206DR
260-92.43-82.2257806245112.41117.2416.0110511863.59539349DR

CSLLY - Frequently Asked Questions (FAQ)

What is the current Csl Ltd (QX) share price?
The current share price of Csl Ltd (QX) is US$ 19,98
How many Csl Ltd (QX) shares are in issue?
Csl Ltd (QX) has 478.911.979 shares in issue
What is the market cap of Csl Ltd (QX)?
The market capitalisation of Csl Ltd (QX) is USD 9,57B
What is the 1 year trading range for Csl Ltd (QX) share price?
Csl Ltd (QX) has traded in the range of US$ 16,01 to US$ 89,71 during the past year
What is the PE ratio of Csl Ltd (QX)?
The price to earnings ratio of Csl Ltd (QX) is 28,51
What is the cash to sales ratio of Csl Ltd (QX)?
The cash to sales ratio of Csl Ltd (QX) is 2,54
What is the registered address of Csl Ltd (QX)?
The registered address for Csl Ltd (QX) is 655 Elizabeth Street, Melbourne, Victoria, 3000
What is the Csl Ltd (QX) website address?
The website address for Csl Ltd (QX) is www.csl.com
Which industry sector does Csl Ltd (QX) operate in?
Csl Ltd (QX) operates in the Biotechnology & Life Sciences sector

CSLLY Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen